Intangible Assets and Goodwill (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Intangible Assets [Line Items] | ||
| Impairment loss | $ 39,572,129 | |
| Intangible assets | $ 15,827 | |
| RPK Biopharma Unipessoal Lda. (“RPK”) [Member] | ||
| Intangible Assets [Line Items] | ||
| Intangible assets at carrying value | 3,783,117 | |
| Cannabis API Manufacturing and GMP License [Member] | ||
| Intangible Assets [Line Items] | ||
| Intangible assets at carrying value | $ 15,827 | |
| Cannabis Distribution License [Member] | ||
| Intangible Assets [Line Items] | ||
| Intangible assets at carrying value | 17,009 | |
| Intangible Assets [Member] | ||
| Intangible Assets [Line Items] | ||
| Intangible assets |
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of reversal of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Reversal of impairment loss recognised in other comprehensive income; Intangible assets other than goodwill] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|